Sponsors Might Share Research Committees As Pressure Mounts To Share Data
Executive Summary
Novartis official says the firm is considering using the same committee as other sponsors to review requests from researchers for data access; stakeholders ask for seats at the table and data interoperability.
You may also be interested in...
Research Consortia Need Funding, But FDA Is More “Honest Broker”
FDA wants data standards in place so the increasingly popular clinical research collaborations can continue growing, but a researcher states that government also could make funding available to sustain the consortia.
Clinical Data Sharing Could Increase Research Costs, Industry Fears
NIH-funded investigators may direct money away from research to prepare their data for public release; some wonder whether grants should include the cost.
Narcolepsy Meeting Focuses On Symptoms, But Some Urge Attention To Underlying Cause
In the fourth meeting conducted under FDA’s patient-focused drug development initiative, dozens of narcoleptics talked about the symptoms they would like new therapies to address. However, some patients said new drugs should go beyond providing mere symptom relief and target the root of the condition.